Index Biosystems Inc. – Trademark Portfolio

Entity Type: 03

Index Biosystems Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include BIOTAG. The owner is based in Toronto.

Suite 300

Toronto M2N6S6 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BIOTAG
BIOTAG
Registered 2021

Trademark Classifications

Index Biosystems Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Index Biosystems Inc. have?

Index Biosystems Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Index Biosystems Inc. file in?

Index Biosystems Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Index Biosystems Inc.'s most well-known trademarks?

Index Biosystems Inc.'s registered trademark portfolio includes well-known marks such as BIOTAG. These are among 1 currently registered trademark in the portfolio.

What is Index Biosystems Inc.'s trademark registration success rate?

Index Biosystems Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.